Iqvia Holdings (IQV) Income from Non-Controlling Interests (2012 - 2026)

Iqvia Holdings (IQV) posted Income from Non-Controlling Interests of $2.0 million for Q2 2026, up 100.0% sequentially from $1.0 million in Q1 2026.

Iqvia Holdings (IQV) Income from Non-Controlling Interests (2012 - 2026) Analysis & Trends

Iqvia Holdings has reported Income from Non-Controlling Interests for 12 years, with the latest figure at $2.0 million in Q2 2026.

Quarterly Income from Non-Controlling Interests changed N/A year-over-year to $2.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $4.0 million (changed N/A YoY) and the FY2025 annual result came in at $1.0 million, changed N/A from the prior year.
Income from Non-Controlling Interests rose to $2.0 million in Q2 2026 per IQV's latest filing, from $1.0 million in the prior quarter.
Over five years, Income from Non-Controlling Interests peaked at $2.0 million in Q2 2026 and troughed at $1.0 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inc. Minority (Qtr)
1	Thermo Fisher Scientific	234.15 Bn	230.09 Bn	8.34 Bn	5.00 Mn
2	Danaher	152.10 Bn	147.75 Bn	3.61 Bn	-
3	Natera	48.48 Bn	47.38 Bn	486.15 Mn	-
4	Agilent Technologies	44.35 Bn	42.55 Bn	990.00 Mn	-
5	Iqvia Holdings	43.68 Bn	41.60 Bn	1.44 Bn	2.00 Mn
6	Idexx Laboratories	43.02 Bn	42.83 Bn	779.09 Mn	-
7	Illumina	34.39 Bn	33.22 Bn	770.00 Mn	-
8	Mettler Toledo International	28.29 Bn	28.24 Bn	650.22 Mn	-
9	Labcorp Holdings	27.51 Bn	27.37 Bn	1.11 Bn	400,000.00
10	Quest Diagnostics	27.10 Bn	26.47 Bn	1.03 Bn	14.00 Mn

Download Data